Edesa Biotech, Inc.EDSANASDAQ
Loading
Year-over-year net income growth rate
Percentile
P54
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | -0.87% |
| Q3 2025 | -27.37% |
| Q2 2025 | -10.00% |
| Q1 2025 | 1.66% |
| Q4 2024 | -68.10% |
| Q3 2024 | 42.33% |
| Q2 2024 | 10.38% |
| Q1 2024 | -10.90% |
| Q4 2023 | 2.44% |
| Q3 2023 | 13.33% |
| Q2 2023 | 14.97% |
| Q1 2023 | -1.88% |
| Q4 2022 | 17.92% |
| Q3 2022 | 51.62% |
| Q2 2022 | -26.27% |
| Q1 2022 | -4.35% |
| Q4 2021 | -18.79% |
| Q3 2021 | 22.55% |
| Q2 2021 | -110.60% |
| Q1 2021 | 14.32% |
| Q4 2020 | -30.93% |
| Q3 2020 | -14.09% |
| Q2 2020 | -18.54% |
| Q1 2020 | -36.12% |
| Q4 2019 | -14.72% |
| Q3 2019 | 26.28% |
| Q2 2019 | 21.88% |
| Q1 2019 | -17.84% |
| Q4 2018 | -24.51% |
| Q3 2018 | 2.39% |
| Q2 2018 | 14.48% |
| Q1 2018 | 3.44% |
| Q4 2017 | -14.73% |
| Q3 2017 | -0.05% |
| Q2 2017 | -10.57% |
| Q1 2017 | 25.71% |
| Q4 2016 | -10.77% |
| Q3 2016 | -12.32% |
| Q2 2016 | -38.68% |
| Q1 2016 | 47.17% |